CD274 and neoplasm: However, there was no significant difference between the CM and PD-L1 inhibitor groups or between the CM + PD-L1 inhibitor and control groups, indicating that CM and immunosuppressant treatment could improve the quality of life of mice and enhance the anti-tumor growth effects of immunosuppressant (Figure 1A).